Nomura Holdings Inc Summit Therapeutics Inc. Transaction History
Nomura Holdings Inc
- $46 Billion
- Q2 2025
A detailed history of Nomura Holdings Inc transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Nomura Holdings Inc holds 43,956 shares of SMMT stock, worth $837,361. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43,956
Previous 95,114
53.79%
Holding current value
$837,361
Previous $2.02 Million
53.8%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding SMMT
# of Institutions
273Shares Held
92.4MCall Options Held
4.71MPut Options Held
3.17M-
Baker Bros. Advisors LP New York, NY33.7MShares$642 Million7.27% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.4MShares$217 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$150 Million0.0% of portfolio
-
State Street Corp Boston, MA4.02MShares$76.5 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.91MShares$74.4 Million0.01% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $3.83B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...